GSK の近くに to 取引，協定 to build £400m science campus in UK that could create 5,000 高度に 技術d 職業s

By Calum Muirhead, 財政上の Mail On Sunday

Updated:

Ambitious: Emma Walmsley plans to split GSK in two

Ambitious: Emma Walmsley 計画（する）s to 分裂（する） GSK in two

GSK is の近くに to a 取引，協定 to build a £400million science campus in the UK that could create 5,000 高度に 技術d 職業s as part of a 最高の-告発（する），告訴（する）／料金d growth 計画（する）.?

The 麻薬s 巨大（な） has been 捜し出すing a 所有物／資産／財産 developer to transform 33 acres of land it owns in Stevenage into one of Europe's biggest 蜂の巣s for 生命科学 start-ups. It is 推定する／予想するd to make an 告示 imminently.?

The move to create a biotech 神経 centre in the Hertfordshire town is part of an ambitious 戦略 drawn up by 長，指導者 (n)役員／(a)執行力のある Emma Walmsley to revitalise GSK's 信任状 as a 生命科学 innovator.?

The City is 熱望して を待つing the 最新の results of GSK's 裁判，公判 next month of what it hopes will be a new blockbuster ワクチン. The group is in a race with America's Pfizer and フラン's Sanofi to 開始する，打ち上げる the first ワクチンs for?RSV, a ありふれた viral respiratory 病気.?

GSK is the world's 主要な ワクチン company, with 広範囲にわたって 賞賛するd 革新s such as its Shingrix jab for shingles, にもかかわらず 落ちるing behind in the race for Covid inoculations.?

Walmsley is 準備するing to 分裂（する） the company into two, separating the 消費者 healthcare brands from the 麻薬s 商売／仕事. She wants to run the 製薬のs 味方する and transform it into a ワクチン and 麻薬s powerhouse.?

The 消費者 arm, Haleon, will 名簿（に載せる）／表（にあげる） on the 在庫／株 交流 as a separate （独立の）存在, with brands 含むing Sensodyne and Panadol.?

GSK will 解放（する） its prospectus for the 分離 within weeks. 文書s will 詳細（に述べる） the 財政上の 手はず／準備 for the break-up ? 含むing how the 会社／堅い's 負債 pile will be 分裂（する） between the two companies.?

French bank Societe Generale said the two 商売／仕事s could be 価値（がある） much more than 以前 thought, with a 連合させるd value of as much as £115billion, up from around £90billion today.?

It 予測（する） that the new GSK 製薬のs 商売／仕事 could be 価値（がある） £18.12 per 株 on its own ? higher than the 現在の 株 price for the whole group. That?would still lag behind Britain's other major 製薬のs group, AstraZeneca, which has a market value of more than £160billion.?

'Spinning off GSK 消費者 in 中央の-July will be a catalyst for both the new 名簿（に載せる）／表（にあげる）d （独立の）存在s,' Societe Generale said in a 報告（する）／憶測.?

The bank believes the new RSV ワクチン could be 'this １０年間's most 構成要素 milestone for New GSK'.?

Construction on the 研究 campus, which will be of 国家の importance in Britain's race to compete globally in the 部門, could begin before the end of this year.?

GSK has a 92-acre 研究 and 開発 場所／位置 in Stevenage and 計画（する）s to 築く the?new 施設 on 未使用の land. The town is already the biggest 独房 and 遺伝子 therapy 研究 cluster in the UK and the third-largest in the world.?

Walmsley, who worked at L'Oreal before joining GSK in 2017, has drawn up a 詳細な計画 for 一貫した growth over the next five years that she hopes will silence her critics and 阻止する predators.?

She has drawn 批評 from 行動主義者 投資家 Elliott 助言者s, which believes the board should consider other 候補者s with more 製薬の experience for the 最高の，を越す 職業.?

Elliott took a 火刑／賭ける in the company after identifying a 重要な underperformance compared with AstraZeneca.?

失望／欲求不満s with GSK 増加するd when it fell behind in the 追求（する），探索（する） to produce a Covid ワクチン.?

Haleon has already been a 的 for 入札者s and more 申し込む／申し出s could 現れる after it is 名簿（に載せる）／表（にあげる）d on the 在庫／株 交流. Unilever made a £50billion 企て，努力，提案 for the 商売／仕事 and it 現れるd last week that Nestle has also made a 企て，努力，提案.?

GSK is 直面するing other problems, 含むing 投票（する）s in April by 労働者s at several British 工場／植物s owned by the company to go on strike over 支払う／賃金.?

Unions have criticised a 'derisory' 2.75 per cent rise as a '相当な real-条件 支払う／賃金 削減（する）'.?

The board has also 苦しむd an 投資家 反乱 over (n)役員／(a)執行力のある remuneration.?

Nearly 40 per cent of 投票（する）ing 株主s …に反対するd the company's remuneration 政策 に引き続いて the introduction of a more generous 特別手当 計画／陰謀 for (n)役員／(a)執行力のあるs.?

Walmsley was paid £8.2million last year and has earned £34million since taking the 職業 in 2017.?

Some links in this article may be (v)提携させる(n)支部，加入者 links. If you click on them we may earn a small （売買）手数料，委託（する）／委員会／権限. That helps us 基金 This Is Money, and keep it 解放する／自由な to use. We do not 令状 articles to 促進する 製品s. We do not 許す any 商業の 関係 to 影響する／感情 our 編集（者）の independence.

Most watched Money ビデオs

Comments 9

株 what you think

The comments below have not been 穏健なd.

The 見解（をとる）s 表明するd in the contents above are those of our 使用者s and do not やむを得ず 反映する the 見解（をとる）s of MailOnline.

We are no longer 受託するing comments on this article.